Oxford BioMedica and AGI Therapeutics Push On with Drugs That ... - Genetic Engineering News (press release) PDF Print
Genetic Engineering News (press release)The company also says that the FDA supports its goal of pushing on with development of the product in subsets of renal cancer patients and for other cancer ...Oxford Biomedica Announces Interim Results From Phase III TRIST

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.